|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 240.65 DKK | +1.07% |
|
+1.58% | -26.01% |
| 04-10 | Wall Street Gets a CPI Lifeline | |
| 04-10 | Lifemd Inc Announces Foundayo Orforglipron Oral Glp-1 Pill for Weight Management | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 254.5 | 311.3 | 348.3 |
| Spread/Res. | -5.44% | -22.70% | -30.91% |
| Spread/Supp. | +5.32% | +5.32% | +5.32% |
| Support | 228.5 | 228.5 | 228.5 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- NOVO B Stock
- Charts Novo Nordisk A/S
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















